This role extends to CRC and HCC, where it supports tumor growth by enhancing cell survival, proliferation, and metastasis through the PI3K-Akt signaling pathway, which inhibits apoptosis and drives tumor progression [101]. Here, AKT1 is linked to hepatocellular carcinoma.